Doctor Diwan - Sport Gen Z

CEO Dr. Anil Diwan talked with Proactive about the company’s recent FDA application for rare pediatric disease designation for its antiviral candidate NV-387, highlighting both the scientific and ... USA Today: NanoViricides President Dr.

Diwan Interviewed by Mission Matters’ Adam Torres Business Insider: NanoViricides President Dr. Diwan to Present at the BIO CEO & Investor 2019 Event in New York City Tomorrow Feb 12th at 2:30pm NanoViricides President Dr. Diwan to Present at the BIO CEO & Investor 2019 Event in New York City Tomorrow Feb 12th at 2:30pm Detroit Free Press: NanoViricides President Dr. Diwan Interviewed by Mission Matters’ Adam Torres Nasdaq: The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides' Dr.

doctor diwan, Diwan SHELTON, CT / ACCESS Newswire / / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), comments on the new COVID Vaccine policy adopted by the US FDA. The ... The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides' Dr.

doctor diwan, Diwan